Generate a tailored SOP for Dr. Christopher Serago. Improve your application with a focused, well-structured draft.
Christopher F. Serago began his career at Presbyterian University Hospital, University of Pittsburgh Medical Center, after earning his Master’s degree in Radiological Physics from Carnegie Mellon University in 1975. He completed his PhD in Medical Physics at the University of Pittsburgh while working at Presbyterian Hospital. From 1981 to 1992, he served as the Director of Medical Physics at Baptist Hospital in Miami, Florida, overseeing services such as Intraoperative Radiotherapy (IORT) and High Dose Rate (HDR) brachytherapy. In 1992, he joined the faculty of Harvard Medical School and Massachusetts General Hospital, focusing primarily on the treatment of patients with protons using the Harvard Cyclotron. In 1995, he accepted a position at the Mayo Clinic in Jacksonville, Florida, where he served as the chief physicist in radiation oncology and later became the Chair of the Division of Medical Physics. He has been recognized with multiple awards for his contributions in education and service to professional organizations, including the Educator of the Year Award from the Association of Residents in Radiation Oncology and the Walter Mauderli Lifetime Achievement Award from the Florida Chapter of the American Association of Physicists in Medicine. After retiring from the Mayo Clinic in 2020, he took on a part-time role at Yale New Haven Health and has held various positions in professional organizations including leadership roles within the AAPM and the American College of Medical Physics.
Yale School of Medicine • New Haven, CT
Part-time position focusing on clinical and educational activities.
Mayo Clinic • Jacksonville, FL
Oversaw the Division of Medical Physics; involved in clinical, research, and educational activities.
Baptist Hospital • Miami, FL
Managed medical physics operations including IORT and HDR brachytherapy.
Harvard Medical School • Boston, MA
Focused on proton treatment protocols and clinical research.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.